Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japanese Companies Face Diversity Challenges As They Look Outward To Maintain Global Stance

This article was originally published in PharmAsia News

Executive Summary

TOKYO - Top executives at Japan's largest pharmaceutical companies say their biggest challenge in becoming global may be to successfully achieve employee diversity at their Japan offices

You may also be interested in...



Takeda May Take Generic Path In South America, CEO Says

TOKYO - Takeda Pharmaceutical will not be seeking the generic strategy Pfizer plans in Japan, but may make a generic plunge in South America, says the top executive of the largest Japanese pharma

Japan’s 2014 Drug Price Reforms Extend Price Premium Program

The Japanese government has decided to revise its drug pricing policies starting in April 2014. Changes include extending a price premium program for two more years, bundling the pricing of similar generic drugs, and reduced pricing on long-listed drugs.

UsernamePublicRestriction

Register

SC070277

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel